...
首页> 外文期刊>Osteoarthritis and cartilage >Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFbeta-responsive gene.
【24h】

Comparative analysis with collagen type II distinguishes cartilage oligomeric matrix protein as a primary TGFbeta-responsive gene.

机译:与II型胶原蛋白的比较分析将软骨寡聚基质蛋白区分为主要的TGFβ反应基因。

获取原文
获取原文并翻译 | 示例

摘要

OBJECTIVE: This study aims to investigate the regulation of expression of Cartilage oligomeric matrix protein (COMP), which is predominately expressed by chondrocytes and functions to organize the extracellular matrix. Mutations in COMP cause two skeletal dysplasias: pseudoachondroplasia and multiple epiphyseal dysplasia. The mechanism controlling COMP expression during chondrocyte differentiation is still poorly understood. DESIGN: Primary human bone marrow-derived stem cells were induced to differentiate into chondrocyte by pellet cultures. We then compared the temporal expression of COMP with the well-characterized cartilage-specific Type II collagen (Col2a1), and their response to transforming growth factor (TGF)beta and Sox trio (Sox5, 6, and 9) stimulation. RESULTS: COMP and Col2a1 expression are differentially regulated by three distinct mechanisms. First, upregulation of COMP mRNA precedes Col2a1 by several days during chondrogenesis. Second, COMP expression is independent of high cell density but requires TGF-beta1. Induction of COMP mRNA by TGF-beta1 is detected within 2h in the absence of protein synthesis and is blocked by specific inhibitors of the TGFbeta signaling pathway; and therefore, COMP is a primary TFGbeta-response gene. Lastly, while Col2a1 expression is intimately controlled by the Sox trio, overexpression of Sox trio fails to activate the COMP promoter. CONCLUSION: COMP and Col2a1 expression are regulated differently during chondrogenesis. COMP is a primary response gene of TGFbeta and its fast induction during chondrogenesis suggests that COMP is suitable for rapidly accessing the chondrogenic potential of stem cells.
机译:目的:本研究旨在探讨软骨寡聚基质蛋白(COMP)的表达调控,该蛋白主要由软骨细胞表达,并具有组织细胞外基质的功能。 COMP中的突变会导致两种骨骼发育不良:假软骨发育不良和多发性phy骨发育不良。软骨细胞分化过程中控制COMP表达的机制仍知之甚少。设计:通过沉淀培养物诱导原代人骨髓干细胞分化为软骨细胞。然后,我们将COMP的时间表达与特征明确的软骨特异性II型胶原(Col2a1)及其对转化生长因子(TGF)β和Sox trio(Sox5、6和9)刺激的反应进行了比较。结果:COMP和Col2a1表达受到三种不同机制的差异调节。首先,在软骨形成过程中,COMP mRNA的上调在Col2a1之前数天。其次,COMP表达不依赖于高细胞密度,但需要TGF-beta1。在没有蛋白质合成的情况下,在2小时内检测到TGF-beta1对COMP mRNA的诱导,并被TGFbeta信号通路的特异性抑制剂所阻断;因此,COMP是主要的TFGbeta反应基因。最后,虽然Col2a1的表达受Sox三重奏紧密控制,但Sox三重奏的过表达不能激活COMP启动子。结论:软骨形成过程中COMP和Col2a1的表达受到不同的调节。 COMP是TGFβ的主要应答基因,其在软骨形成过程中的快速诱导表明COMP适用于快速获得干细胞的软骨形成潜能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号